Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vaginal gel and preparation method thereof

A technology of vaginal gel and transparent xanthan gum, which is applied in the direction of medical formulas, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., which can solve side effects, high cost, slow effect of traditional Chinese medicine and cannot be relieved in time Symptoms and other problems, to achieve the effect of improving vaginal moisture and promoting repair

Active Publication Date: 2017-04-26
浙江因诺泰医疗器械有限公司
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Currently, the treatment products for vaginitis or vaginal dryness are divided into three categories: 1. Western medicines, such as metronidazole, chlorhexidine, miconazole and ketoconazole, etc., are bactericidal and antibacterial. Western medicines have quick effects but are prone to drug resistance and There are side effects; 2. Traditional Chinese medicine, such as cnidium fruit, flavescens, Phellodendron cortex, alum, licorice, borneol and Kochia scoparia, etc., have the functions of clearing away heat and detoxification, killing insects and relieving itching, and the simple use of traditional Chinese medicine is slow to take effect and cannot relieve symptoms in time; 3. Devices There are two categories, one is treatment with ozone or red light and other physiotherapy equipment, which requires patients to go to the hospital for treatment regularly or purchase treatment equipment by themselves, the cost is high; the other is chitosan, silver ions and other vaginal antibacterial gels, Using biological antibacterial raw materials, instant, convenient, fast and economical treatment of vaginitis, the use and curative effect of the gel have been widely recognized
However, the antibacterial, lubricating and moisturizing effects of current vaginal gel products are not ideal enough

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] A kind of vaginal gel described in this embodiment and preparation method thereof, comprises each component of following mass concentration:

[0023] 1. Macromolecular sodium hyaluronate: 0.2%

[0024] 2. VES-HA: 0.5%

[0025] 3. EGF: 0.001%

[0026] 4. Vitamin C: 0.003%

[0027] 5. Calcium chloride: 0.01%

[0028] 6. Pentylene glycol: 2%

[0029] 7. Glycerin: 10%

[0030] 8. Transparent xanthan gum: 1%

[0031] The molecular weight of the macromolecule sodium hyaluronate is between 400,000 and 1,000,000 Daltons.

[0032] During preparation, add sodium hyaluronate, vitamin E succinate-modified hyaluronic acid, EGF, vitamin C and calcium chloride into deionized water with a total water content of about 98%, and mix until dissolved; Add pentylene glycol, glycerin and transparent xanthan gum and mix until dissolved to obtain a uniform system; add ionized water, stir well, and finally adjust the pH of the mixture gel to 4.5±0.5 with disodium hydrogen phosphate-citric...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to the technical field of preparation of colpitis medicines, and especially relates to a vaginal gel and a preparation method thereof in order to solve the technical problem of unsatisfactory bacteriostasis, lubrication and moisture retention effects of existing vaginal gel products. The vaginal gel mainly comprises sodium hyaluronate, vitamin E succinate modified hyaluronic acid, EGF (epidermal growth factors), vitamins C, calcium chloride, pentanediol, glycerin, Rhodicare and a buffer system adopting disodium hydrogen phosphate-citric acid as gel. The vaginal gel has anti-inflammatory activity, improves the wetness of vaginas, is used for treating vaginal inflammatory diseases and alleviating vaginal dryness or used as a human body lubricant, has a vaginal mucosa squamous cell layer restoration promoting effect, can improve vaginal mucosa layer thinning and restore small injuries in vaginas to recover the elasticity and the softness of the vaginal mucosa, and is suitable for colpitis and vagina dryness people.

Description

technical field [0001] The invention relates to the technical field of vaginitis medicine preparation, in particular to a vaginal gel and a preparation method thereof. Background technique [0002] Vaginitis is a common and frequently-occurring disease in women, including bacterial vaginosis, fungal vaginitis and trichomonas vaginitis. The clinical symptoms of vaginitis are mainly manifested as increased vaginal discharge with peculiar smell, genital itching, and causing cervical and uterine infection and pelvic inflammatory disease. The main population of vaginal dryness or atrophic vaginitis is postmenopausal women. According to survey statistics, about half of postmenopausal women have vaginal dryness. The vaginal mucosa is composed of glycogen-rich nonkeratinized stratified squamous epithelium and a fibrous basement membrane. During the reproductive period, the stratified squamous epithelium is rich in glycogen, and the vaginal mucosa is moist and elastic. After menop...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/06A61K38/18A61K31/728A61K47/36A61K47/24A61P15/02
CPCA61K9/0034A61K9/06A61K31/375A61K31/728A61K38/1808A61K47/24A61K47/36A61K2300/00
Inventor 杨维徐丽君蔡建光童振飞
Owner 浙江因诺泰医疗器械有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products